Skip to content

Home
Our research
Market
Plans
Partnering
About us

Menu

Home
Our research
Market
Plans
Partnering
About us

Follicum planerar emission inför notering på AktieTorget

Follicum planerar emission inför notering på AktieTorget. Läs hela pressmeddelandet här: 2014-10-07 Pressmeddelande

Contact us

Jens Eriksson

Twitter Linkedin Facebook Youtube

As part of Coegin Pharma AB’s hub & spoke “portfolio” business model, with clear benefits to investors, Coegin Pharma AB has established the Swedish portfolio company Follicum AB to further develop a highly promising dermacosmetic product line based on FOL005 to stimulate hair growth. Follicum AB will primarily be managed and financed separately from Coegin Pharma AB.

© All Rights Reserved